Diagnostic work-up of iron deficiency

LaboratoriumsMedizin

Volumn 28, Issue 5, 2004, Pages 391-399

  Metzgeroth, Georgia ^a   Hastka, Jan ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ferritin; Hypochrome erythrocytes; Iron deficiency; Reticulocyte hemoglobin; Soluble transferrin receptor; Zinc protoporphyrin

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANEMIA; CHRONIC DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; FLUOROMETRY; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOASSAY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; LABORATORY DIAGNOSIS; LABORATORY TEST; LEAD POISONING; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MYELODYSPLASTIC SYNDROME; RETICULOCYTE; REVIEW; SCREENING TEST; TRANSFERRIN BLOOD LEVEL;

EID: 8444242944     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2004.054     Document Type: Review

References (56)

1. De Mayer E, Adiels-Teyman M. The prevalence of anemia in the world. World Health Stat Q 1985;38:302-16.
2. Wharton BA. Iron deficiency in children: detection and prevention. Br J Haematol 1999;106:270-80.
3. Hurtado EK, Claussen AH, Scott KG. Early childhood anemia and mild or moderate mental retardation. Am J Nutr 1999;69:115-9.
4. Watkins WE, Pollitt E. Iron deficiency and cognition among school-age children. In: Dopping J, ed. Brain, behavior and iron in infant diet. London: Springer Verlag 1990:179-97.
5. Lozoff B. Has iron deficiency been shown to cause altered behavior in infants? In: Dopping J, ed. Brain, behavior and iron in infant diet. London: Springer Verlag 1990:107-31.
6. Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. In: Nutrition, health and child development. Research advances and policy recommendations. Pan American Health Organization 1998:179-97.
7. Fairbanks VF, Beutler E. Iron deficiency. In Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology New York: McGraw-Hill 1990:482-505.
8. Witte DA. Laboratory tests to confirm or exclude iron deficiency. Lab Med 1985;16:671-5.
9. Heil W, Koberstein R, Zawta B. Referenzbereiche für Kinder und Erwachsene. Roche Diagnostics 2002
10. Hastka J, Lasserre JJ, Schwarzbeck A, Reiter A, Hehlmann R. Laboratory tests of iron status: correlation or common sense? Clin Chem 1996;42:718-24.
11. Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R. Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem 1994;40:768-73.
12. Wong SS, Qutishat AS, Lange J, Gornet TG, Buja LM. Detection of iron-deficiency anemia in hospitalized patients by zinc protoporphyrin. Clin Chim Acta 1996;244:91-101.
13. Labbe RF, Vreman HJ, Stevenson DK. Zinc protoporphyrin: A metabolite with a mission. Clin Chem 1999;45:2060-72.
14. Lamola AA, Yamane T. Zinc protoporphyrin in the erythrocytes of patients with lead intoxication and iron deficiency anemia. Science 1974;186:936-8.
15. Lamola AA, Joselow M, Yamane T. Zinc protoporphyrin (ZPP): a simple, sensitive fluorometric screening test for lead poisoning. Clin Chem 1975;21:93-7.
16. Blumberg WE, Eisinger J, Lamola AA, Zuckerman DM. The hematofluorometer. Clin Chem 1977;23:270-4.
17. Labbe RF, Rettmer RL. Zinc protoporphyrin: a product of iron-deficient erythropoiesis. Semin Hematol 1989; 26:40-6.
18. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R. Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem 1992;38:2184-9.
19. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R. Zinc protoporphyrin in anemia of chronic disorders. Blood 1993;81:1200-4.
20. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R. Zinc protoporphyrin: a screening parameter of iron deficiency and derangements of iron metabolism [Abstract]. Onkologie 1991;14(Suppl 2):62.
21. Gorodetsky R, Fuks Z, Peretz T, Ginsburg H. Elevation of erythrocyte zinc- and free protoporphyrins with metastatic spread in cancer patients. Eur J Cancer Clin Oncol 1986;22:1515-21.
22. Kohgo Y, Niitsu Y, Kondo H, Kato J, Tsushima N, Sasaki K, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987;70:1955-8.
23. Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev 1987;67:520-82.
24. Flowers CH, Skikne BS, Covell AM, Cook JD. The clinical measurement of serum transferrin receptor. J Lab Clin Med 1989;114:368-77.
25. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990;75:1870-6.
26. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75:102-7.
27. Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol 1992;80:278-84.
28. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992;119:385-90.
29. Punnonen K, Irjala K, Rajamaki A. Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 1994;40:774-6.
30. Baynes RD, Skikne BS, Cook JD. Circulating transferrin receptors and assessment of iron status. J Nutr Biochem 1994;5:322.
31. Suominen P, Punnonen K, Rajamaki A, Irjala K. Evaluation of new immunoenzymometric assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. Clin Chem 1997;43:1641-6.
32. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329:9-22.
33. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-7.
34. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor, ferritin and TfR-F index in identification of latent iron deficiency. Eur J Haematol 1998;60:135-7.
35. Suominen P, Punnonen K, Rajamäki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficit. Blood 1998;92:2934-9.
36. Lee EJ, Oh EJ, Park YJ, Lee HK, Kim BK. Soluble transferrin receptor (sTfR), ferritin, and sTfR/Iog ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. Clin Chem 2002;48:1118-21.
37. Thomas C, Thomas E. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-76.
38. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992;304:225-6.
39. Schaefer RM, Schaefer L. Iron monitoring and supplementation: how do we achieve the best results? Nephrol Dial Transplant 1998;13(Suppl 2):9-12.
40. Cullen P, Söffker J, Höpfl M, Bremer C, Schlaghecker R, Mehrens T, et al. Hypochromic red cells and reticulocyte hemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic hemodialysis. Nephrol Dial Transplant 1999;14:650-65.
41. Bovy C, Tsobo C, Crapanzano L, Rorive G, Beguin Y, Albert A, Paulus JM. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney Int 1999;56:1113-9.
42. Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001;16:1416-23.
43. European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 1999;14:14-5.
44. Brugnara C, Hipp MJ, Irving P, Lathrop H, Lee P, Minchello E, Winkelman J. Automated reticulocyte counting and measurement of reticulocyte cellular indices. Am J Clin Pathol 1994;102:623-32.
45. Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003;18:370-377.
46. Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Int Suppl 1999;69:S44-8.
47. Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997;30:912-22.
48. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997;52:217-22.
49. Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Plat O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999;281:2225-30.
50. Onofrio G, Chirillo R, Zini G, Caenaro G, Tommasi M, Micciulli G. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 85:818-23.
51. Hörl WH. Measurement of hypochromic red blood cells is not the first line procedure to identify the patient with iron deficiency. Nephrol Dial Transplant 1998;13:850-1.
52. Skarmoutsou C, Papassotiriou I, Traeger-Synodinos J, Stamou H, Ladis V, Metaxotou-Mavrommati A, et al. Erythroid bone marrow activity and red cell hemoglobinization in iron-sufficient β-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin content. Correlation with genotypes and Hb A2 levels. Hematologica 2003;88:631-6.
53. Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Van Dieijen-Visser MP, et al. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. J Nephrol 2004;17:107-11.
54. Cartwright GE, Lee GR. The anemia of chronic disorders. Br J Haematol 1971;21:147.
55. Lee GR. The anemia of chronic disease. Semin Hematol 1983;20:61.
56. Littlewood J. The efficacy of rHuEPO in cancer-related anemia. Br J Haematol 2003;121:3-11.